Decoy Therapeutics Inc. · NASDAQ:DCOY
Marschel Peter Klaus received 3,900 Decoy Therapeutics Inc. shares as an award (Form 4)
Traded Aug 31, 2026 · Filed Sep 2, 2026
On Aug 31, 2026, Marschel Peter Klaus (Chief Business Officer) received 3,900 Decoy Therapeutics Inc. shares as an award, leaving 3,900 shares. Filed Sep 2, 2026 (Form 4).
- Awarded
- 3,900 shares
- Holding after
- 3,900 shares
- Trading plan
- No
- Role
- Chief Business Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Award | 3,900 | 3,900 | Direct |